Role of MMP7 on the Prognosis of Peritoneal Dialysis Patients: a Single-Center Ambispective Cohort Study

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100043377

Enrollment

Unknown

Registered

2021-02-12

Start date

2015-06-01

Completion date

Unknown

Last updated

2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End stage renal disease patients receiving peritoneal dialysis treatment

Interventions

Low MMP7 levels group:none

High MMP7 levels group:none

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients undergoing PD for more than 3 months and aged 18 years or older, with baseline clinical data and serum samples were eligible for this study from June 1st, 2015 to December 31th, 2025.

Exclusion criteria

Exclusion criteria: Patients who did not want to participate in the study, or with irregular peritoneal dialysis treatment, or irregular follow-up (never follow-up after PD catheter implantation, or follow-up less than once a year after dialysis were excluded.

Design outcomes

Primary

Measure	Time frame
Incidence of CHF;Incidence of new hyperphosphatemia;New secondary hyperparathyroidism;	—

Secondary

Measure	Time frame
PD withdrawal;Combined endpoint;Overall mortality;	—

Countries

China

Contacts

Public ContactJun Ai

Nanfang Hospital, Southern Medical University

aij1980@163.com+86 13570972948

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026